Cargando…

Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice

Atopic dermatitis (AD) is a chronic recurrent skin disease dominated by T-helper 2 inflammation. Momelotinib (MMB) is a novel JAK1/JAK2 inhibitor suppressing the signal transduction of multiple pro-inflammatory cytokines. Recent studies indicated that JAK inhibitor could play a therapeutic role in A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Wenyu, Huang, Wei, Chen, Liqing, Jin, Mingji, Wang, Qiming, Gao, Zhonggao, Jin, Zhehu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321094/ https://www.ncbi.nlm.nih.gov/pubmed/30544712 http://dx.doi.org/10.3390/ijms19123973

Ejemplares similares

Anti-Inflammatory Effects of M-MSCs in DNCB-Induced Atopic Dermatitis Mice
por: Ryu, Bokyeong, et al.
Publicado: (2020)

Improving the anti-keloid outcomes through liposomes loading paclitaxel–cholesterol complexes
por: Wang, Mengjiao, et al.
Publicado: (2019)

Inhibitory Effect of Bisdemethoxycurcumin on DNCB-Induced Atopic Dermatitis in Mice
por: Wang, Yanjie, et al.
Publicado: (2022)

A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia
por: Verstovsek, Srdan, et al.
Publicado: (2017)

Momelotinib (JAK1/JAK2/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis
por: Tefferi, Ayalew, et al.
Publicado: (2023)

Topical Spilanthol Inhibits MAPK Signaling and Ameliorates Allergic Inflammation in DNCB-Induced Atopic Dermatitis in Mice
por: Huang, Wen-Chung, et al.
Publicado: (2019)

Establishment and Characterization of Mild Atopic Dermatitis in the DNCB-Induced Mouse Model
por: Riedl, Rebecca, et al.
Publicado: (2023)

Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
por: Iznardo, Helena, et al.
Publicado: (2023)

A New Horizon for Atopic Dermatitis Treatments: JAK Inhibitors
por: Tampa, Mircea, et al.
Publicado: (2023)

The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis
por: Bao, Lei, et al.
Publicado: (2013)

Immunomodulatory and Anti-inflammatory Effects of Asiatic Acid in a DNCB-Induced Atopic Dermatitis Animal Model
por: Moon, Gyo-Ha, et al.
Publicado: (2021)

JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
por: Huang, I-Hsin, et al.
Publicado: (2022)

Salvianolic Acid A Suppresses DNCB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice
por: Jeon, Wi-Jin, et al.
Publicado: (2021)

The mechanism of oxymatrine on atopic dermatitis in mice based on SOCS1/JAK-STAT3 pathway
por: Han, Xianwei, et al.
Publicado: (2023)

Comparative phenotypic profiling of the JAK2 inhibitors ruxolitinib, fedratinib, momelotinib, and pacritinib reveals distinct mechanistic signatures
por: Singer, Jack W., et al.
Publicado: (2019)

Oral Administration of Sargassum horneri Improves the HDM/DNCB-Induced Atopic Dermatitis in NC/Nga Mice
por: Han, Eui Jeong, et al.
Publicado: (2020)

Fermented rice bran prevents atopic dermatitis in DNCB-treated NC/Nga mice
por: Saba, Evelyn, et al.
Publicado: (2016)

Lycopus lucidus Turcz ameliorates DNCB-induced atopic dermatitis in BALB/c mice
por: Min, Ga-Yul, et al.
Publicado: (2021)

Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/Nga mice
por: Kim, Young-Je, et al.
Publicado: (2018)

Gardenia Jasminoides Ameliorates Antibiotic-Associated Aggravation of DNCB-Induced Atopic Dermatitis by Restoring the Intestinal Microbiome Profile
por: Kim, Hyo In, et al.
Publicado: (2021)

JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results
por: Szalus, Krzysztof, et al.
Publicado: (2020)

Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis
por: Kiely, Lisa, et al.
Publicado: (2022)

Optimal Use of Jak Inhibitors and Biologics for Atopic Dermatitis on the Basis of the Current Evidence
por: Kamata, Masahiro, et al.
Publicado: (2023)

The Anti-Atopic Dermatitis Effects of Mentha arvensis Essential Oil Are Involved in the Inhibition of the NLRP3 Inflammasome in DNCB-Challenged Atopic Dermatitis BALB/c Mice
por: Kim, So-Yeon, et al.
Publicado: (2023)

Anti-inflammatory effect of quercetin and galangin in LPS-stimulated RAW264.7 macrophages and DNCB-induced atopic dermatitis animal models
por: Lee, Hae Nim, et al.
Publicado: (2018)

In Vivo Optical Reporter-Gene-Based Imaging of Macrophage Infiltration of DNCB-Induced Atopic Dermatitis
por: Lee, Sang Bong, et al.
Publicado: (2020)

Effect of Neferine on DNCB-Induced Atopic Dermatitis in HaCaT Cells and BALB/c Mice
por: Yang, Chung-Chi, et al.
Publicado: (2021)

Inhibitory Effects of Donkey Hide Gelatin on DNCB-Induced Atopic Dermatitis in NC/Nga Mice
por: Lee, Ju Hyun, et al.
Publicado: (2022)

Inhibitory Effect of Centella asiatica Extract on DNCB-Induced Atopic Dermatitis in HaCaT Cells and BALB/c Mice
por: Lee, Yonghyeon, et al.
Publicado: (2020)

Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients
por: Torres, Tiago, et al.
Publicado: (2021)

Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis
por: Kopalli, Spandana Rajendra, et al.
Publicado: (2022)

Protective effect of diet supplemented with rice prolamin extract against DNCB-induced atopic dermatitis in BALB/c mice
por: Yoon, Hyun-Joong, et al.
Publicado: (2015)

Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
por: Morris, Gabriela M., et al.
Publicado: (2018)

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib
por: Nezamololama, Novin, et al.
Publicado: (2020)

The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review
por: Tsiogka, Aikaterini, et al.
Publicado: (2022)

Inhibitory effect of Isatis tinctoria L. water extract on DNCB-induced atopic dermatitis in BALB/c mice and HaCaT cells
por: Min, Ga-Yul, et al.
Publicado: (2022)

Anti-Atopic Effect of Isatidis Folium Water Extract in TNF-α/IFN-γ-Induced HaCaT Cells and DNCB-Induced Atopic Dermatitis Mouse Model
por: Min, Ga-Yul, et al.
Publicado: (2023)

7,8,4′-Trihydroxyisoflavone Attenuates DNCB-Induced Atopic Dermatitis-Like Symptoms in NC/Nga Mice
por: Kim, Heejung, et al.
Publicado: (2014)

Solanum nigrum Linne improves DNCB-induced atopic dermatitis-like skin disease in BALB/c mice
por: Hong, Sooyeon, et al.
Publicado: (2020)

Caffeoyl–Pro–His amide relieve DNCB-Induced Atopic Dermatitis-Like phenotypes in BALB/c mice
por: Jang, Sunhyae, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l9g92t0bldo1jejqkus8lnble6